Submission Details
| 510(k) Number | K190151 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 30, 2019 |
| Decision Date | February 25, 2019 |
| Days to Decision | 26 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K190151 is an FDA 510(k) clearance for the COBRA Fusion Ablation System, a Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (Class II — Special Controls, product code OCL), submitted by AtriCure, Inc. (West Chester, US). The FDA issued a Cleared decision on February 25, 2019, 26 days after receiving the submission on January 30, 2019. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 878.4400.
| 510(k) Number | K190151 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 30, 2019 |
| Decision Date | February 25, 2019 |
| Days to Decision | 26 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | OCL — Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4400 |
| Definition | Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |